Search

The CP reviews hospitalized patient's medication record, Lab investigations, ensures proper medication reconciliation along with communication with healthcare providers in daily rounds, to optimize patient's pharmacotherapy plan. If the patient had been experiencing issues with the medication in question, or if there was a strong probability of the medication causing issues in the future, the pharmacist contacted the provider that prescribed the medication in question via EHR direct message. In 2021, clinical pharmacists at HJAHC developed a program to collaborate with pharmacy students to identify and intervene on those patients who were omitted treatment for the following quality measures: 1) use of antithrombotic drugs in patients 18 years or older with ischemic vascular disease (IVD) and/or, 2) use of statins for the prevention of cardiovascular events in patients 21 years or older with, or at risk for developing, cardiovascular disease. Upon review of eligible patients for empagliflozin in 2021, only 18 patients with HF and 5 patients with ischemic stroke were identified. Two clinical pharmacists determined patient eligibility for empagliflozin, performed medication reconciliation, provided medication and disease state education, obtained prior authorizations, and phoned patients to follow up on day-7 and day-21 post-discharge. [Extracted from the article]